Pancreatic Cancer Research

ResearcherSichuan UniversityNo recent work listed

Jiaxing Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9176-8901; OpenAlex author ID A5074027508. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

  1. S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial. First author DOI 10.1080/14737167.2020.1677155↗
  2. Cost-effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial. Co-author DOI 10.2147/cmar.s172704↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kexun Zhou · 2 shared papers, 2018–2020 · strength 0.18
  2. Qiu Li · 2 shared papers, 2018–2020 · strength 0.18
  3. Weiting Liao · 2 shared papers, 2018–2020 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.